A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Completed
Berry Consultants
Phase 2/Phase 3
2008-08-01
This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects
of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring
glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type
2 diabetes mellitus on Metformin.
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Completed
Tessella Inc.
Phase 2/Phase 3
2008-08-01
This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects
of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring
glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type
2 diabetes mellitus on Metformin.
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Completed
United BioSource Corporation
Phase 2/Phase 3
2008-08-01
This is an adaptive dose finding study and a Phase 3 efficacy study to evaluate the effects
of once weekly injection of LY2189265 compared to Sitagliptin on glucose by measuring
glycosylated hemoglobin (HbA1c) change from baseline after 52 weeks in participants with type
2 diabetes mellitus on Metformin.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.